Fulton Bank’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-3,199
Closed -$213K 430
2016
Q4
$213K Sell
3,199
-959
-23% -$62.4K 0.02% 381
2016
Q3
$275K Sell
4,158
-886
-18% -$60.6K 0.03% 347
2016
Q2
$365K Sell
5,044
-4,292
-46% -$295K 0.04% 303
2016
Q1
$603K Sell
9,336
-336
-3% -$22.3K 0.06% 197
2015
Q4
$693K Sell
9,672
-416
-4% -$30.8K 0.07% 181
2015
Q3
$775K Sell
10,088
-179
-2% -$14.4K 0.09% 169
2015
Q2
$761K Sell
10,267
-13
-0.1% -$936 0.08% 187
2015
Q1
$745K Sell
10,280
-181
-2% -$12.6K 0.08% 189
2014
Q4
$692K Buy
10,461
+56
+0.5% +$3.42K 0.08% 181
2014
Q3
$571K Buy
10,405
+113
+1% +$6.41K 0.07% 190
2014
Q2
$599K Buy
+10,292
New +$606K 0.07% 191

Other funds holding MD

Fulton Bank's MD Position: Q1 2017 in Review

Fulton Bank sold out of Pediatrix Medical (MD) in Q1 2017, closing a stake of 3,199 shares — an estimated $213K sold.

Fulton Bank first reported a position in MD in Q2 2014 and held it in 11 quarters. The position peaked at $775K in Q3 2015. 359 funds tracked by Wall St. Rank hold MD as of Q1 2017.

  • Fulton Bank reported no remaining Pediatrix Medical position as of Q1 2017 after selling out during the quarter.
  • Fulton Bank sold 3,199 Pediatrix Medical shares in Q1 2017, an estimated $213K.
  • Fulton Bank first reported a position in Pediatrix Medical in Q2 2014 and held it in 11 quarters.
  • Fulton Bank's Pediatrix Medical position peaked at $775K in Q3 2015.
  • 359 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2017.

Based on Fulton Bank's 13F filing for Q1 2017, filed 6 Apr 2017.